Top Markets
Coin of the day
Synairgen plc Synairgen plc

Synairgen plc

SNG
Rang in Aktien #40400
Synairgen plc specializes in the research and development of pharmaceutical... Synairgen plc specializes in the research and development of pharmaceutical treatments for various respiratory conditions. Its product pipeline includes SNG001, an inhaled interferon beta currently being developed for COVID-19. The company is also advancing an inhaled form of interferon beta (IFN-ß) through Phase II clinical trials for the management of asthma triggered by common colds and influenza, as well as for the treatment or prevention of chronic obstructive pulmonary disease. Furthermore, Synairgen is developing a LOXL2 inhibitor intended for treating idiopathic pulmonary fibrosis (IPF). To support the development of this LOXL2 inhibitor, the company maintains a licensing and collaboration agreement with Pharmaxis Ltd. Synairgen plc was established in 2004 and is headquartered in Southampton, United Kingdom.
Aktienkurs
$0.01292666
Zuletzt synchronisiert: 2025-04-08
Marktkapitalisierung
$157.54K
Veränderung (1 Tag)
6.84%
Veränderung (1 Jahr)
0.00%
Land
GB
Handel Synairgen plc (SNG)

Kategorie

P/B-Verhältnis für Synairgen plc (SNG)
P/B-Verhältnis zum August 2026 TTM: 0.15
Laut den neuesten Finanzberichten und dem Aktienkurs von Synairgen plc beträgt das aktuelle Kurs-Buchwert-Verhältnis (TTM) 0.15. Am Ende des Jahres 2022 lag das P/B-Verhältnis bei 0.97.
P/B-Verlauf für Synairgen plc von 2004 bis 2026
P/B-Verhältnis zum Jahresende
Jahr P/B-Verhältnis ändert
2026 (TTM) 0.15 -78.10%
2023 0.69 -29.11%
2022 0.97 -88.10%
2021 8.13 326.23%
2020 1.91 -7.27%
2019 2.06 -99.86%
2018 1.50K 26.76%
2017 1.18K -39.85%
2016 1.97K -1.83%
2015 2.01K -7.72%
2014 2.17K 11,509.79%
2013 18.72 170.50%
2012 6.92 224.88%
2011 2.13 16.99%
2010 1.82 206.96%
2009 0.59 -73.97%
2008 2.28 35.55%
2007 1.68 -99.48%
2006 322.75 18.54%
2005 272.28 1,051.93%
2004 23.64 0.00%
P/B-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/B-Verhältnis P/B-Verhältnis-Differenz Land
6.2613 4,043.81%
US
6.3483 4,101.39%
NL
- -
CH
- -
KR
3.634 2,305.03%
BE